Skip to main content
Antioxidants logoLink to Antioxidants
. 2019 Sep 1;8(9):344. doi: 10.3390/antiox8090344

How Does Pyridoxamine Inhibit the Formation of Advanced Glycation End Products? The Role of Its Primary Antioxidant Activity

Rafael Ramis 1,2, Joaquín Ortega-Castro 1,2,*, Carmen Caballero 1,2, Rodrigo Casasnovas 1,2, Antonia Cerrillo 1,2, Bartolomé Vilanova 1,2, Miquel Adrover 1,2, Juan Frau 1,2
PMCID: PMC6770850  PMID: 31480509

Abstract

Pyridoxamine, one of the natural forms of vitamin B6, is known to be an effective inhibitor of the formation of advanced glycation end products (AGEs), which are closely related to various human diseases. Pyridoxamine forms stable complexes with metal ions that catalyze the oxidative reactions taking place in the advanced stages of the protein glycation cascade. It also reacts with reactive carbonyl compounds generated as byproducts of protein glycation, thereby preventing further protein damage. We applied Density Functional Theory to study the primary antioxidant activity of pyridoxamine towards three oxygen-centered radicals (•OOH, •OOCH3 and •OCH3) to find out whether this activity may also play a crucial role in the context of protein glycation inhibition. Our results show that, at physiological pH, pyridoxamine can trap the •OCH3 radical, in both aqueous and lipidic media, with rate constants in the diffusion limit (>1.0 × 108 M1 s1). The quickest pathways involve the transfer of the hydrogen atoms from the protonated pyridine nitrogen, the protonated amino group or the phenolic group. Its reactivity towards •OOH and •OOCH3 is smaller, but pyridoxamine can still scavenge them with moderate rate constants in aqueous media. Since reactive oxygen species are also involved in the formation of AGEs, these results highlight that the antioxidant capacity of pyridoxamine is also relevant to explain its inhibitory role on the glycation process.

Keywords: pyridoxamine, DFT, AGEs, inhibition, ROS

1. Introduction

Protein glycation involves a sequence of nonenzymatic reactions between proteins and sugars. The pathological complications of diabetes (kidney diseases [1], retinopathies [2], vascular diseases [3] and neurodegenerative diseases [4]) are directly related to the effects of these reactions on the structure and function of the affected proteins. The general mechanism of protein glycation starts with the addition of a nucleophilic group of a protein to the carbonyl group of glucose to form a Schiff base, which can subsequently yield an α-ketoamine known as an Amadori compound. Schiff bases and Amadori compounds can slowly and irreversibly evolve towards the so-called advanced glycation end products (AGEs) through a heterogeneous set of reactions [4,5,6].

AGEs can also be generated by several side reactions that occur in parallel to the general mechanism. These generally consist of metal-catalyzed oxidations of Schiff bases or Amadori compounds that yield reactive oxygen species (ROS) and reactive carbonyl species (RCS). Since ROS and RCS are much more reactive than glucose, their ability to damage proteins is much higher, as they enhance the number and type of AGEs that are formed [6,7,8,9].

Given the pathological implications of protein glycation, the design of molecules with the ability to attenuate its effects is a matter of utmost concern. The three main mechanisms by which these molecules, known as protein glycation inhibitors, prevent the formation of AGEs are: (i) the complexation of metal ions that catalyze the secondary reactions of protein glycation; (ii) the scavenging of RCS; and (iii) ROS generated as byproducts of those secondary reactions. In 1999, it was discovered that pyridoxamine (PM) had the ability of inhibiting the oxidation of Amadori compounds to form AGEs [10]. PM is one of the three natural forms of vitamin B6, together with pyridoxal (PL) and pyridoxine (PN). By that time, it was known that PM was very reactive towards carbonyl groups, since it acted as a coenzyme in transamination reactions between carbonyl compounds and amino groups [11], and this led to consider that it could be an effective AGE inhibitor. Thus far, several studies in both animal and human models have shown its therapeutic effects on diabetic kidney disease [12,13], as well as on retinopathies [14] and vascular diseases [15].

Concerning its mechanism of action, it has been suggested that PM could be effective as a metal chelating agent, a RCS scavenger and/or a ROS scavenger. It can form stable complexes with Cu2+ and Fe3+ [16,17] and stable adducts with several dicarbonyl compounds [18,19,20,21], as well as inhibit the production of the hydroxyl radical from the Fenton reaction or directly react with it [22,23,24]. Some studies also suggest that it can eliminate the superoxide radical anion from the medium [25], while others dispute this conclusion [24].

There exist several experimental assays to evaluate the antioxidant activity of molecules [26,27], but they neither distinguish between oxidant species nor allow the determination of the preferred mechanisms and reaction sites. For these reasons, theoretical methods such as DFT are particularly well suited to assess antioxidant activities. Some DFT studies on the reactivity of PN, another form of vitamin B6, towards hydroxyl, hydroperoxyl and superoxide were carried out by Matxain and coworkers [28,29]. Galano et al. also studied the antioxidant capacity of many different organic molecules by using this methodology [30,31,32,33,34].

Here, we aimed to study the ability of PM to scavenge ROS and to determine its preferred mechanisms and reaction sites by applying DFT. This would allow us to complete our previous studies on the formation of complexes between PM and Cu2+ or Fe3+ [35,36,37] and on its reactivity towards RCS [16,18,38,39] in the context of AGE inhibition. Specifically, thermodynamic and kinetic data were computed for all reaction paths between PM and the hydroxyl (•OOH), methylperoxyl (•OOCH3) and methoxyl (•OCH3) radicals, as well as their branching ratios (that is, the contribution of each path to the overall reactivity of PM). These radicals were chosen because using a highly reactive one such as hydroxyl could lead to the conclusion that all reaction paths are equally likely [40,41]. Three different mechanisms were studied: hydrogen-atom transfer, radical-adduct formation and single-electron transfer.

2. Materials and Methods

The quantum mechanics-based test for overall free radical scavenging activity (QM-ORSA) methodology, as explained by Galano et al. [42], was applied to compute the rate constants of the reactions between PM and the •OOH, •OOCH3 and •OCH3 radicals. Briefly, the geometries of PM and each radical, as well as the reaction products and transition states (TSs), were optimized at the M05-2X/6-311+G(d,p) level of theory. The unrestricted formalism was applied to open-shell systems, and the ultrafine integration grid was used in all the calculations. The M05-2X functional was designed for thermochemistry, thermochemical kinetics and noncovalent interactions [43], and successfully used for kinetic calculations and reaction energies in antioxidant-free radical systems [44,45,46]. After the geometry optimizations, frequencies were calculated to obtain Gibbs free energies for each species and to confirm the nature of the stationary points. Minima had no imaginary frequencies, while TSs had exactly one. The values of these imaginary frequencies are given in Tables S1 and S2. For each TS, the atom displacement associated to the imaginary frequency was coincident with the motion along the expected reaction coordinate.

Solvent effects were included in all geometry optimizations by using the universal SMD implicit solvation model [47]. Two different solvents, water and pentyl ethanoate, were used to mimic an aqueous and a lipidic microenvironment, respectively. The cationic form of PM, which is the predominant one at physiological pH (7.4) [48], was modeled in water. This form has three different tautomers with a significant mole fraction at pH 7.4 [37] (Figure 1) and all three were used in the calculations. In pentyl ethanoate, only the completely neutral form was considered. Three reaction mechanisms were studied: (i) the transfer of each hydrogen atom from PM to the radical (hydrogen-atom transfer, HAT); (ii) the formation of an adduct between PM and the radical at each aromatic atom (radical-adduct formation, RAF); and (iii) and the transfer of an electron (single-electron transfer, SET) from PM to the radical.

Figure 1.

Figure 1

Atom numbering for the four pyridoxamine (PM) tautomers considered for calculations in water (H2PM(±), H2PM(+) and H2PM(0)) and pentyl ethanoate (HPM(0)). Mole fractions χ at physiological pH (7.4), calculated from the pKa values collected by Casasnovas et al. [37], are also indicated.

For each reaction, its standard reaction Gibbs free energy ΔG0 at 298.15 K was calculated as the difference between the Gibbs free energies of products and reactants, and only the reactions with a ΔG0 less than 1 kcal/mol were considered for the kinetic study. In these cases, activation Gibbs free energies ΔG at 298.15 K were calculated as the differences between the Gibbs free energies of TSs and reactants. These ΔG values are shown in Tables S3 and S4. All ΔG0 and ΔG values were referred to the standard state of 1 M. Solvent cage effects were considered by applying the corrections suggested by Okuno [49], based on the free volume theory [50].

Rate constants k were calculated by applying conventional transition state theory (TST) by using Equation (1):

k=κσkBTheΔGRT, (1)

where kB is the Boltzmann constant; h is the Planck constant; R is the ideal gas constant; T is the absolute temperature; κ is the tunneling correction; and σ is the reaction path degeneracy, which takes into account the existence of different but equivalent reaction paths. Tunneling corrections κ were applied when computing the rate constants for the HAT reactions by considering an Eckart barrier [51], as implemented in the program by Brown et al. [52]. Tables S1 and S2 display the values of κ for all HAT reactions. For RAF reactions, no tunneling corrections were applied (κ = 1).

When rate constants k were above the diffusion limit (k > 1.0 × 108 M1 s1), the Kimball–Collins theory [53] was used to correct them by applying Equation (2):

kapp=kDkkD+k, (2)

where kD is the steady-state Smoluchowski rate constant for a diffusion-controlled, bimolecular, irreversible reaction, which is obtained from Equation (3) [54]:

kD=4πRDABNA, (3)

where R is the reaction distance; NA is the Avogadro number; and DAB is the mutual diffusion coefficient for the reactants A and B, calculated as the sum of their diffusion coefficients DA and DB, which are calculated with the Stokes–Einstein approach, given by Equation (4) [55,56]:

Di=kBT6πηai, (4)

where kB is the Boltzmann constant; T is the absolute temperature; η is the solvent viscosity (8.91 × 10−4 Pa·s for water and 8.62 × 10−4 Pa·s for pentyl ethanoate); and ai is the radius of solute i, assuming it is spherical.

Overall rate constants for each combination of radical, solvent, mechanism and reaction site were calculated as the sums of the rate constants for each tautomer, weighted by their mole fractions χi at physiological pH (7.4), as shown in Equation (5):

koverall=i=1nχiki, (5)

where ki is the rate constant for the ith tautomer and n is the number of tautomers (3 for water and 1 for pentyl ethanoate). Total rate constants ktot were computed for each combination of radical and solvent as the sum of the overall rate constants for all mechanisms and reaction sites, as shown in Equation (6):

ktot=koverall, (6)

Branching ratios Γ were also calculated for each combination of radical, solvent, mechanism and reaction site by using Equation (7):

Γ=100·koverallktot. (7)

All geometry optimizations and frequency calculations were performed with the Gaussian 09 package, revision D.01 [57].

3. Results

The thermodynamics and kinetics of the different reaction pathways between PM and the •OOH, •OOCH3 and •OCH3 radicals were determined and analyzed in this study, both in a polar solvent (water) and in a nonpolar solvent (pentyl ethanoate). Three mechanisms were considered:

  • Hydrogen-atom transfer (HAT): PM + R•→ PM(-H)• + RH, considering each possible PM hydrogen atom.

  • Radical-adduct formation (RAF): PM + R•→ [PM-R]•, at each aromatic PM atom.

  • Single-electron transfer (SET): PM + R•→ PM+• + R.

In water, the H2PM(±), H2PM(+) and H2PM(0) tautomers of the monocationic form of PM were considered, whereas only the neutral form HPM(0) was modeled in pentyl ethanoate (Figure 1).

3.1. Thermodynamic Study

Thermodynamically, •OCH3 is by far the most reactive of the three studied radicals in both solvents, and •OOH is slightly more reactive than •OOCH3 (Table 1). The standard reaction Gibbs free energies (ΔG0) for all HAT reactions in water involving •OCH3 are 18.5 kcal/mol lower than those with •OOH at the same position, and 19.1 kcal/mol lower than those with •OOCH3. ΔG0 values for RAF reactions in water involving •OCH3 are between 13.8 and 16.9 kcal/mol lower than the corresponding reactions involving •OOH and between 15.7 and 19.7 kcal/mol lower than those with •OOCH3. For SET reactions, the ΔG0 values for •OCH3 are also lower than those for the other two radicals, although the differences are smaller: 5.5 kcal/mol in the case of •OOH and 7.3 kcal/mol in the case of •OOCH3.

Table 1.

Standard reaction Gibbs free energies ΔG0 (in kcal/mol), at 298.15 K and 1 bar, for each combination of reaction site, pyridoxamine tautomer in water and free radical. See Figure 1 for nomenclature.

H2PM(±) H2PM(+) H2PM(0)
•OOH •OOCH3 •OCH3 •OOH •OOCH3 •OCH3 •OOH •OOCH3 •OCH3
HAT-C6 33.9 34.5 15.4 34.0 34.6 15.5 23.7 24.3 5.2
HAT-C7 −2.1 −1.5 −20.6 2.2 2.8 −16.3 4.6 5.2 −13.9
HAT-C8 −0.7 −0.1 −19.2 −12.7 −12.1 −31.2 8.7 9.3 −9.8
HAT-C9 −1.3 −0.7 −19.8 −1.8 −1.2 −20.3 3.3 3.9 −15.2
HAT-N1 −1.4 −0.8 −19.9 26.5 27.1 8.0 - -
HAT-N2 10.1 10.6 −8.4 13.5 14.1 −5.0 26.7 27.3 8.2
HAT-O1 - - - 25.4 12.1 −7.0 13.9 0.6 −18.5
HAT-O2 29.8 30.4 11.3 19.0 19.6 0.5 19.4 20.0 0.9
RAF-N1 - - - - - - 42.7 - 27.6
RAF-C2 −5.3 −2.9 −20.5 11.4 15.3 −4.3 12.8 16.2 −1.0
RAF-C3 20.7 22.2 4.1 17.9 19.5 2.0 15.2 17.3 0.2
RAF-C4 0.9 2.8 −15.4 13.3 16.8 −2.9 17.6 20.3 0.7
RAF-C5 19.9 21.5 4.1 19.6 19.8 3.1 16.2 18.2 1.8
RAF-C6 −2.5 0.4 −17.4 11.8 13.1 −2.6 10.5 13.6 −3.7
SET 26.3 28.1 20.8 62.0 63.8 56.5 41.5 43.3 36.0

HAT: Hydrogen-atom transfer. RAF: Radical-adduct formation. SET: Single-electron transfer. The letter and number next to each abbreviation indicate the reaction site, as defined in Figure 1.

In pentyl ethanoate, the trends are the same (Table 2). ΔG0 values for HAT reactions with •OCH3 are 18.3 kcal/mol lower than those involving •OOH and 19.8 kcal/mol lower than those with •OOCH3. For RAF reactions, the differences are between 12.9 and 15.6 kcal/mol for •OOH and between 16.8 and 19.3 kcal/mol for •OOCH3. The ΔG0 for the SET reaction involving •OCH3 in pentyl ethanoate is 8.1 kcal/mol lower than that for •OOH and 9.4 kcal/mol lower than that for •OOCH3.

Table 2.

Standard reaction Gibbs free energies ΔG0 (in kcal/mol), at 298.15 K and 1 bar, for each combination of reaction site and free radical in pentyl ethanoate. See Figure 1 for nomenclature.

HPM(0)
•OOH •OOCH3 •OCH3
HAT-C6 23.1 24.6 4.8
HAT-C7 5.6 7.0 −12.8
HAT-C8 −0.2 1.2 −18.5
HAT-C9 0.3 1.7 −18.0
HAT-N2 19.2 20.6 0.9
HAT-O1 6.9 8.3 −11.4
HAT-O2 19.7 21.1 1.3
RAF-N1 42.6 - 29.3
RAF-C2 11.1 15.0 −1.8
RAF-C3 14.8 19.3 0.0
RAF-C4 13.8 17.2 −1.8
RAF-C5 16.1 18.8 1.1
RAF-C6 10.7 15.6 −3.6
SET 89.4 90.7 81.3

HAT: Hydrogen-atom transfer. RAF: Radical-adduct formation. SET: Single-electron transfer. The letter and number next to each abbreviation indicate the reaction site, as defined in Figure 1.

The most exergonic reaction pathway for the scavenging of •OCH3 in water is the abstraction of the C8 hydrogen atom of the H2PM(+) tautomer (ΔG0 = −31.2 kcal/mol). In general, the HAT reactions at the C7, C8 and C9 of all three tautomers in water are highly exergonic pathways for the scavenging of this radical. In addition, hydrogen abstractions from the N1 and N2 of H2PM(±) and from the O1 of H2PM(0), as well as the RAF reactions at the C2, C4 and C6 of H2PM(±), are thermodynamically favored pathways for the scavenging of •OCH3. There are other pathways that could also be thermodynamically possible, although with smaller negative (or even slightly positive) ΔG0 values: the HAT reactions at N2, O1 and O2 and the radical additions at C2, C4 and C6 of H2PM(+); and the HAT reaction at O2 and the radical additions at C2, C3, C4 and C6 of H2PM(0). In pentyl ethanoate, the trends do not vary much. The thermodynamically most favored mechanism to scavenge •OCH3 is the HAT reaction at C8 (ΔG0 = −18.5 kcal/mol), followed by the HAT reactions at C9, C7 and O1. The RAF reactions at C2, C3, C4 and C6, and the HAT reaction at N2 could be feasible as well, since their ΔG0 values are either slightly negative or slightly positive. All other pathways, such as the hydrogen abstractions from the sp2 carbon (C6) and especially the SET reactions, are clearly endergonic.

The most negative ΔG0 values for the scavenging of both •OOH and •OOCH3 in water also correspond to the abstraction of a hydrogen atom from the C8 of H2PM(+) (i.e., −12.7 and −12.1 kcal/mol, respectively). In pentyl ethanoate, the most favorable pathways for these two radicals are the same as in water, although with ΔG0 values close to 0 (−0.2 and 1.2 kcal/mol, respectively). All the other pathways either have ΔG0 values around 0 (i.e., hydrogen abstractions from the C7, C8, C9 and N1 atoms and radical additions to the C2, C4 and C6 atoms of H2PM(±); hydrogen abstraction from the C9 of H2PM(+) and, in the case of •OOCH3, from the O1 of H2PM(0)), or are clearly endergonic (e.g., hydrogen abstractions from the aromatic C6 atom and SET reactions).

In most cases, the radical adducts at N1 are not stable (their optimization results in their dissociation). In the few cases in which they do not dissociate, their formation is largely endergonic (ΔG0 values between 27.6 and 42.7 kcal/mol).

All pathways characterized as clearly endergonic (ΔG0 > 1 kcal/mol) were discarded as possible mechanisms to explain the ability of PM to scavenge ROS because, even if they took place at a significant rate, they would be reversible. Nevertheless, they would represent possible pathways if their products further reacted, in subsequent steps, with small activation barriers and high exergonicity.

3.2. Kinetic Study

Those reaction mechanisms with ΔG0 values below 1 kcal/mol were further analyzed from a kinetic point of view. The •OCH3 radical is the one exhibiting the highest rate constants. The H2PM(±) tautomer, which is predominant at physiological pH, is also the most reactive. It seems that •OCH3 may react with rate constants higher than the diffusion limit (>1.0 × 108 M1 s1) by several mechanisms (Table 3 and Table 4): (i) via a HAT reaction at the N1 and N2 sites of the H2PM(±) tautomer and at the phenolic oxygen (O1) of the H2PM(+), H2PM(0) and HPM(0) tautomers; or (ii) through a RAF reaction at the C6 site of the H2PM(±) tautomer. For the mentioned HAT reactions involving the •OCH3 radical, no TS could be located at the level of theory used. However, a relaxed scan of the X-H distances (where X is N1, N2 or O1), leading from reactants to products, revealed a monotonic decrease of the energy (with no maximum along the way), suggesting that these reactions are strictly diffusion-controlled (i.e., every encounter between the reactants would yield the products). In contrast, we could find the TS corresponding to the diffusion-controlled •OCH3 RAF reaction at the C6 atom of H2PM(±) (Figure 2). The structures and the Cartesian coordinates of all TSs found in this study are given in the Supplementary Materials. Other pathways with high rate constants for the scavenging of •OCH3 are the formation of a radical adduct at the C2 and C4 positions of H2PM(±) (in the order of 107 and 106 M1 s1, respectively). Moderate rate constants are found for •OCH3 HAT reactions at the aliphatic carbon atoms (C7, C8 and C9) of all four tautomers (in the order of 103–106 M1 s1).

Table 3.

Rate constants k (in M1 s1), at 298.15 K and 1 bar, for those combinations of reaction site, pyridoxamine tautomer and free radical where the standard reaction Gibbs free energy is less than 1 kcal/mol. See Figure 1 for nomenclature.

H2PM(±) H2PM(+) H2PM(0) HPM(0)
•OOH •OOCH3 •OCH3 •OOH •OOCH3 •OCH3 •OCH3 •OOH •OCH3
HAT-C7 2.8 × 101 2.8 × 100 3.3 × 105 - - 1.4 × 105 1.0 × 105 - 2.0 × 104
HAT-C8 1.1 × 100 1.1 × 10−1 4.2 × 104 1.8 × 100 2.7 × 100 9.6 × 104 4.2 × 103 4.0 × 101 1.7 × 106
HAT-C9 6.8 × 10−1 2.8 × 10−1 7.0 × 105 2.9 × 100 1.8 × 10−1 3.1 × 105 1.8 × 105 1.1 × 100 7.3 × 104
HAT-N1 - - 2.9 × 109 - - - - - -
HAT-N2 - - 2.8 × 109 - - 5.6 × 101 - - 1.7 × 102
HAT-O1 - - - - - 3.0 × 109 2.9 × 109 - 3.0 × 109
HAT-O2 - - - - - 2.8 × 10−1 5.6 × 10-2 - -
RAF-C2 3.1 × 104 1.1 × 104 9.1 × 107 - - 6.1 × 10−1 3.9 × 100 - 1.1 × 102
RAF-C3 - - - - - - 1.2 × 101 - 3.5 × 103
RAF-C4 1.1 × 102 - 6.4 × 106 - - 3.8 × 104 1.6 × 100 - 9.5 × 103
RAF-C6 9.9 × 103 2.1 × 102 2.1 × 108 - - 1.8 × 100 2.8 × 103 - 1.5 × 104

HAT: Hydrogen-atom transfer. RAF: Radical-adduct formation. The letter and number next to each abbreviation indicate the reaction site, as defined in Figure 1.

Table 4.

Overall rate constants koverall (in M1 s1) and branching ratios, at 298.15 K and 1 bar, and at physiological pH (7.4), for each free radical in each solvent at each reaction site. Total rate constants ktot (in M1 s1), calculated as the sum of all koverall for each radical in each solvent, are also indicated. See Figure 1 for nomenclature.

Water Pentyl Ethanoate
•OOH •OOCH3 •OCH3 •OOH •OCH3
HAT-C7 2.1 × 101 (<0.1%) 2.1 × 100 (<0.1%) 2.8 × 105 (<0.1%) ≈0 2.0 × 104 (<0.1%)
HAT-C8 1.1 × 100 (<0.1%) 4.1 × 10−1 (<0.1%) 4.4 × 104 (<0.1%) 4.0 × 101 (97.3%) 1.7 × 106 (<0.1%)
HAT-C9 8.7 × 10−1 (<0.1%) 2.4 × 10−1 (<0.1%) 6.0 × 105 (<0.1%) 1.1 × 100 (2.7%) 7.3 × 104 (<0.1%)
HAT-N1 ≈0 ≈0 2.2 × 109 (42.0%) - -
HAT-N2 ≈0 ≈0 2.2 × 109 (41.2%) ≈0 1.7 × 102 (<0.1%)
HAT-O1 ≈0 ≈0 6.6 × 108 (12.4%) ≈0 3.0 × 109 (99.9%)
HAT-O2 ≈0 ≈0 3.9 × 10-2 (<0.1%) ≈0 ≈0
•OOH •OOCH3 •OCH3 •OOH •OCH3
RAF-C2 2.4 × 104 (75.6%) 8.1 × 103 (98.0%) 6.9 × 107 (1.3%) ≈0 1.1 × 102 (<0.1%)
RAF-C3 ≈0 ≈0 1.2 × 100 (<0.1%) ≈0 3.5 × 103 (<0.1%)
RAF-C4 8.6 × 101 (0.3%) ≈0 4.9 × 106 (0.1%) ≈0 9.5 × 103 (<0.1%)
RAF-C6 7.6 × 103 (24.0%) 1.6 × 102 (1.9%) 1.6 × 108 (3.1%) ≈0 1.5 × 104 (<0.1%)
ktot 3.2 × 104 8.3 × 103 5.3 × 109 4.2 × 101 3.0 × 109

HAT: Hydrogen-atom transfer. RAF: Radical-adduct formation. The letter and number next to each abbreviation indicate the reaction site, as defined in Figure 1.

Figure 2.

Figure 2

Transition state for the RAF reaction between the H2PM(±) tautomer of pyridoxamine and the •OCH3 radical at C6, which is the fastest reaction for which a transition state was located. The distance between the oxygen atom of •OCH3 and the C6 atom of H2PM(±) is given in Å.

The other two radicals are not particularly reactive at any position, with only moderate rate constants for the RAF reactions at the C2 and C6 atoms of H2PM(±) (in the order of 104 and 103 M1 s1, respectively, for •OOH; and in the order of 104 and 102 M1 s1, respectively, for •OOCH3) and at its C4 atom (in the order of 102 M1 s1 for •OOH). The rate constants at the remaining thermochemically viable sites are negligible (<102 M1 s1). For the HAT reactions at the N1 atom of H2PM(±) involving •OOH and •OOCH3, and for the HAT reaction at the O1 atom of H2PM(0) involving •OOCH3, again no TSs could located at the level of theory used. However, as opposed to the case of •OCH3, a relaxed scan of the X-H distances (where X is N1 or O1) resulted in a monotonic increase of the energy (with no maximum along the way) when moving from reactants to products, suggesting that, in these cases, the inverse HAT reactions (i.e., the transfer of hydrogen from the radicals to PM) are the ones that are strictly diffusion-controlled. Therefore, these reactions were also discarded as viable pathways for the scavenging of these radicals.

PM would be able to scavenge the •OCH3 radical in an aqueous environment with a total rate constant (ktot) of 5.3 × 109 M1 s1 (Table 4), with HAT reactions at both nitrogen atoms N1 and N2 and at the phenolic oxygen O1 as the preferred reaction pathways (branching ratios of 42.0%, 41.2% and 12.4%, respectively). In a lipidic medium, the scavenging of •OCH3 would also be diffusion-controlled, with a ktot value of 3.0 × 109 M1 s1, being the HAT reaction at the phenolic oxygen the unique non-negligible pathway. The other two radicals would be moderately scavenged in an aqueous environment, with ktot values of 3.2 × 104 and 8.3 × 103 M1 s1 for •OOH and •OOCH3, respectively. In the case of •OOH, the scavenging would take place mainly through the formation of radical adducts at the C2 and C6 atoms (branching ratios of 75.6% and 24.0%, respectively), and in the case of •OOCH3, the single preferred pathway would be the formation of a radical adduct at C2 (with a branching ratio of 98.0%). In a lipidic environment, however, PM would not efficiently scavenge •OOH or •OOCH3 (ktot values below 102 M1 s1; for •OOCH3, none of the studied pathways would be thermochemically feasible).

3.3. Comparison to Other Studies

Matxain et al. reported a DFT study on the reactivity of PN with •OH, •OOH and •O2 [28]. The study concluded, from thermodynamical considerations, that •OH would preferentially abstract a hydrogen atom from any of the methylene moieties or from the phenol group (ΔG0 between −33 and −39 kcal/mol), while it could also form adducts at the aromatic C atoms adjacent to the pyridine nitrogen (i.e., C2 and C6) (ΔG0 around −6 kcal/mol). On the other hand, •OOH would only react at the same two aromatic C atoms (ΔG0 around −7 kcal/mol) and •O2 would not react at all. Despite focusing on a different vitamin B6 vitamer and using a different DFT functional (B3LYP), these results are in qualitative agreement with our kinetic study, which shows that, in the case of PM, the phenol hydrogen abstraction is among the preferred routes for the more reactive •OCH3 radical (koverall≈ 109 M1 s1) with hydrogen abstractions from the methylene groups (C8 and C9) being also highly favorable (koverall≈ 104–106 M1 s1), while the less reactive •OOH and •OOCH3 radicals would be preferentially scavenged via additions at C2 and/or C6 (koverall≈ 102–104 M1 s1). The difference is that, unlike the PN model used in the study by Matxain et al., PM displays additional tautomers containing a protonated pyridine nitrogen or a protonated amino group that also represent preferred HAT reaction sites.

The differences in thermodynamics and kinetics among the three studied radicals are in line with their different stabilities: peroxyl radicals ROO• are much more stable than corresponding alkoxyl radicals RO• due to electron donation from the adjacent oxygen lone pairs to the half-empty orbital on the terminal oxygen (hence, •OOCH3 is much more stable than •OCH3), and the methyl group in •OOCH3 also makes it slightly more stable than •OOH due to electron density donation. The more stable a radical is, the less reactivity it will show, hence •OOCH3 is much less reactive than •OCH3 and slightly less reactive than •OOH. Identical reactivity trends are obtained in many similar DFT studies of antioxidant-free radical reactions [31,32,58], including a recent investigation on the thermodynamics of HAT reactions between cinnamic acid derivatives and ten oxygen-centered radicals of different nature, in both water and pentyl ethanoate [59].

Considering that •OOH and •OOCH3 are less reactive than other free radicals, overall rate constants in water in the order of 104 and 103 M1 s1, respectively, for their reactions with PM indicate a notorious radical scavenging ability. The overall rate constant for •OOH is similar to that of antioxidants such as capsaicin (2.07 × 104 M1 s1) [58] or β-carotene (5.69 × 104 M1 s1) [60] and better than that of allicin (8 × 103 M1 s1) [61] or melatonin (2 × 101 M1 s1) [34]. However, it does not perform as well as α-tocopherol (1.5 × 105–7.9 × 106 M1 s1) [62], canolol (2.47 × 106 M1 s1) [33], most guaiacol derivatives (1.54 × 105–1.65 × 107 M1 s1) [63] or sesamol (2.44 × 108 M1 s1) [64].

4. Discussion

Although the active form of vitamin B6 in our bodies is pyridoxal 5’-phosphate (PLP) and in food it is mainly present as PN, PM has been regarded as the vitamin B6 vitamer with the highest ability to inhibit post-Amadori reactions and, consequently, the formation of AGEs [23,65]. For this reason, the present study focuses specifically on this form of vitamin B6 to shed new light on one of the possible mechanisms underlying this inhibitory activity. The other two forms have also been reported to show antioxidant activity [66,67] and the aforementioned study on the ROS trapping ability of PN [28] shows that it shares some of the preferred reaction sites with PM (namely, the phenol group, the methylene moieties and the aromatic carbons adjacent to the pyridine nitrogen). Since PLP also displays all these structural elements, it is plausible that it also scavenges ROS by similar mechanisms.

PM has been proven to act therapeutically on diabetic rats and humans displaying renal, retinal or cardiovascular dysfunctions [12,13,14,15]. Several attempts to elucidate its mechanism of action have pointed PM as a potent inhibitor of post-Amadori reactions, both in vitro and in vivo [23]. Over the past decade, our group has studied the reactivity of PM towards several carbohydrates and other carbonyls with a notorious glycation potential. Our results revealed that PM can form Schiff bases with rate constants one order of magnitude higher than those for the same reactions occurred on amino acids [19,38]. These results suggest that PM is also an effective inhibitor of the first stages of the protein glycation process.

Our group has also conducted studies on the ability of PM to trap different model Amadori compounds and to chelate different metal cations which catalyze their autoxidation [16]. These studies concluded that the key to explain the inhibitory activity of PM is its strong metal chelation ability and not its interaction with Amadori intermediates, in agreement with a previous work by Voziyan and colleagues [68]. This conclusion was further supported by two DFT studies showing that PM could compete against a model Amadori compound to chelate Cu2+ and Fe3+, while aminoguanidine could not, thereby explaining the fact that aminoguanidine cannot prevent the oxidation of Amadori compounds despite its ability to chelate metal ions [35,36]. Although PM does not interact directly with the carbonyl group of Amadori compounds, it can inhibit its degradation to many small RCS such as glyoxal, methylglyoxal and glycolaldehyde [20,69,70].

In the 2000s, several works additionally suggested a potent antioxidant activity of vitamin B6, comparable to that of α-tocopherol or ascorbic acid [71,72,73,74,75]. In fact, PM is able to scavenge the ABTS+• radical cation used in the TEAC assay, although relatively slowly [76]. Subsequent theoretical studies carried out by Matxain and coworkers showed that PN, another form of vitamin B6, is highly reactive towards singlet oxygen [77] and hydroxyl radicals [28,29] but not against superoxide [28]. The transfer of the phenolic hydrogen atom could contribute significantly to this antioxidant activity [78], in perfect agreement with our findings. Furthermore, a recent study showing that PM reduces the levels of intracellular ROS induced by the glycation of the human serum albumin protein, further supports the idea that PM is a powerful antioxidant [79].

The study reported herein strengthens the hypothesis that PM can inhibit protein glycation and the cellular damage induced by its side reactions through the efficient scavenging of ROS. We have proved that PM would efficiently trap reactive radical species such as •OCH3 and, in an aqueous environment, it would be moderately reactive towards peroxyl (•OOH) or alkyl peroxyl radicals such as •OOCH3. This ability of PM to trap ROS would complement its activity as a metal chelator and as a small RCS scavenger in the context of post-Amadori inhibition of AGEs formation.

Two limitations of this study should be pointed out. The first one is that only the monocationic tautomers of PM have been modeled in water, since more than 99% of PM exists in this form at physiological pH. However, if any of the dicationic, neutral or monoanionic tautomers were reactive enough, this fact would compensate its low mole fraction and it would have a non-negligible role in ROS scavenging. The second one is that only the three most common mechanisms (HAT, RAF and SET) for antioxidant-free radical reactions have been considered, but alternative mechanisms might also contribute. In any case, in either of these two scenarios the conclusion that PM is a potent ROS scavenger would still hold. An interesting follow-up of this study would be the modeling of ROS scavenging by PLP, with the same methodology used herein, to compare the results with PM and find out whether it could act in a similar way in the context of AGE formation inhibition.

5. Conclusions

In this study, the primary antioxidant activity of PM, one of the natural forms of vitamin B6, together with PN and PL, was investigated by performing DFT calculations at the M05-2X/6-311+G(d,p)/SMD level of theory. The results show that PM is an effective scavenger of the •OCH3 radical, in both aqueous (ktot = 5.3 × 109 M1 s1) and lipidic (ktot = 3.0 × 109 M1 s1) microenvironments, and a moderate scavenger of •OOH and •OOCH3 in aqueous media (ktot = 3.2 × 104 and 8.3 × 103 M1 s1, respectively), but not in a lipidic media (ktot = 4.2 × 101 and ≈0 M1 s1, respectively). From the kinetic point of view, the preferred mechanisms to trap the •OCH3 radical are the diffusion-controlled transfer of the hydrogen atoms from the protonated pyridine, from the protonated amino group, and from the phenolic oxygen atom. Hydrogen-atom transfer reactions from the methylene groups in the –CH2NH3 and the –CH2OH ring substituents are also favorable pathways (rate constants in the order of 104–106 M1 s1). On the other hand, the formation of radical adducts on the aromatic carbon atoms adjacent to the pyridine nitrogen atom would be preferred when scavenging the •OOH and •OOCH3 radicals. These results add to our previous studies on the mechanisms by which PM inhibits post-Amadori reactions in the context of protein glycation by showing that, besides its strength as a metal chelator and its reactivity towards small carbohydrates and reactive carbonyl species, its ability to scavenge reactive oxygen species also plays a significant role.

Acknowledgments

The authors are grateful to “Consorci de Serveis Universitaris de Catalunya (CSUC)”, the “Centro de Cálculo de Supercomputación de Galicia (CESGA)”, and the “Centre de Tecnologies de la Informació (CTI) de la UIB” for providing access to their computational facilities. R.R. acknowledges his Ph.D. scholarship granted by the Spanish Ministerio de Educación, Cultura y Deporte (MECD) within the FPU program (FPU16/00785).

Abbreviations

The following abbreviations are used in this manuscript:

AGE Advanced glycation end product
ROS Reactive oxygen species
RCS Reactive carbonyl species
NMR Nuclear magnetic resonance
DFT Density functional theory
PM Pyridoxamine
PL Pyridoxal
PN Pyridoxine
PLP Pyridoxal 5’-phosphate
QM-ORSA Quantum mechanics-based test for overall free radical scavenging activity
TS Transition state
SMD Solvation Model based on the quantum mechanical charge Density of a solute molecule interacting with a continuum
HAT Hydrogen atom transfer
RAF Radical adduct formation
SET Single electron transfer
TST Transition state theory

Supplementary Materials

The following are available online at https://www.mdpi.com/2076-3921/8/9/344/s1, Table S1 : Imaginary frequencies and κ values for TSs in water, Table S2: Imaginary frequencies and κ values for TSs in pentyl ethanoate, Table S3: Gibbs free energies of activation for reactions in water, TableS4: Gibbs free energies of activation for reactions in pentyl ethanoate, Cartesian coordinates and figures of all located TSs.

Author Contributions

Conceptualization, J.F. and B.V.; methodology, R.R., C.C. and A.C.; formal analysis, R.R.; investigation, R.R., C.C. and A.C.; writing—original draft preparation, R.R.; writing—review and editing, J.O.-C., J.F., M.A. and R.C.; visualization, R.R.; supervision, J.F. and B.V.; project administration, J.F. and B.V.; and funding acquisition, J.F. and B.V.

Funding

This research was funded by the Ministerio de Economía y Competitividad (MINECO) and the European Fund for Regional Development (FEDER) (CTQ2014-55835-R), and by the Conselleria d’Educació, Cultura i Universitats (Ajuts a accions especials d’R+D AAEE49/2015).

Conflicts of Interest

The authors declare no conflict of interest.

References

  • 1.Bohlender J.M., Franke S., Stein G., Wolf G. Advanced Glycation End Products and the Kidney. Am. J. Physiol. Ren. Physiol. 2005;289:645–659. doi: 10.1152/ajprenal.00398.2004. [DOI] [PubMed] [Google Scholar]
  • 2.Stitt A.W. The Maillard Reaction in Eye Diseases. Ann. N. Y. Acad. Sci. 2005;1043:582–597. doi: 10.1196/annals.1338.066. [DOI] [PubMed] [Google Scholar]
  • 3.Kume S., Takeya M., Mori T., Araki N., Suzuki H., Horiuchi S., Kodama T., Miyauchi Y., Takahashi K. Immunohistochemical and Ultrastructural Detection of Advanced Glycation End Products in Atherosclerotic Lesions of Human Aorta with a Novel Specific Monoclonal Antibody. Am. J. Pathol. 1995;147:654–667. [PMC free article] [PubMed] [Google Scholar]
  • 4.Thorpe S.R., Baynes J.W. Maillard Reaction Products in Tissue Proteins: New Products and New Perspectives. Amino Acids. 2003;25:275–281. doi: 10.1007/s00726-003-0017-9. [DOI] [PubMed] [Google Scholar]
  • 5.Brownlee M. Advanced Protein Glycosylation in Diabetes and Aging. Annu. Rev. Med. 1995;46:223–234. doi: 10.1146/annurev.med.46.1.223. [DOI] [PubMed] [Google Scholar]
  • 6.Ulrich P., Cerami A. Protein Glycation, Diabetes, and Aging. Recent. Prog. Horm. Res. 2001;56:1–21. doi: 10.1210/rp.56.1.1. [DOI] [PubMed] [Google Scholar]
  • 7.Reynolds T.M. Chemistry of Nonenzymatic Browning II. Adv. Food Res. 1965;14:167–283. doi: 10.1016/s0065-2628(08)60149-4. [DOI] [PubMed] [Google Scholar]
  • 8.Rahbar S., Figarola J.L. Inhibitors and Breakers of Advanced Glycation Endproducts (AGEs): A Review. Curr. Med. Chem. Immun. Enodcrinol. Metab. Agents. 2002;2:135–161. doi: 10.2174/1568013023358889. [DOI] [Google Scholar]
  • 9.Monnier V.M. Intervention Against the Maillard Reaction in Vivo. Arch. Biochem. Biophys. 2003;419:1–15. doi: 10.1016/j.abb.2003.08.014. [DOI] [PubMed] [Google Scholar]
  • 10.Khalifah R.G., Baynes J.W., Hudson B.G. Amadorins: Novel Post-Amadori Inhibitors of Advanced Glycation Reactions. Biochem. Biophys. Res. Commun. 1999;257:251–258. doi: 10.1006/bbrc.1999.0371. [DOI] [PubMed] [Google Scholar]
  • 11.Snell E.E. The Vitamin B6 Group. V. The Reversible Interconversion of Pyridoxal and Pyridoxamine by Transamination Reactions. J. Am. Chem. Soc. 1945;67:194–197. doi: 10.1021/ja01218a013. [DOI] [Google Scholar]
  • 12.Degenhardt T.P., Alderson N.L., Arrington D.D., Beattie R.J., Basgen J.M., Steffes M.W., Thorpe S.R., Baynes J.W. Pyridoxamine Inhibits Early Renal Disease and Dyslipidemia in the Streptozotocin-Diabetic Rat. Kidney Int. 2002;61:939–950. doi: 10.1046/j.1523-1755.2002.00207.x. [DOI] [PubMed] [Google Scholar]
  • 13.Murakoshi M., Tanimoto M., Gohda T., Hagiwara S., Ohara I., Toyoda H., Ishikawa Y., Horikoshi S., Tomino Y. Pleiotropic Effect of Pyridoxamine on Diabetic Complications Via CD36 Expression in KK-Ay/Ta Mice. Diabetes Res. Clin. Pract. 2009;83:183–189. doi: 10.1016/j.diabres.2008.11.008. [DOI] [PubMed] [Google Scholar]
  • 14.Stitt A., Gardiner T.A., Alderson N.L., Canning P., Frizzell N., Duffy N., Boyle C., Januszewski A.S., Chachich M., Baynes J.W., et al. The AGE Inhibitor Pyridoxamine Inhibits Development of Retinopathy in Experimental Diabetes. Diabetes. 2002;51:2826–2832. doi: 10.2337/diabetes.51.9.2826. [DOI] [PubMed] [Google Scholar]
  • 15.Wu E., Liang J., Wu M., Chang K. Pyridoxamine Prevents Age-Related Aortic Stiffening and Vascular Resistance in Association with Reduced Collagen Glycation. Exp. Gerontol. 2011;46:482–488. doi: 10.1016/j.exger.2011.02.001. [DOI] [PubMed] [Google Scholar]
  • 16.Adrover M., Vilanova B., Frau J., Muñoz F., Donoso J. The Pyridoxamine Action on Amadori Compounds: A Reexamination of its Scavenging Capacity and Chelating Effect. Bioorg. Med. Chem. 2008;16:5557–5569. doi: 10.1016/j.bmc.2008.04.002. [DOI] [PubMed] [Google Scholar]
  • 17.Thompson D.M., Balenovich W., Hornich L.H.M., Richardson M.R. Reactions of Metal Ions With Vitamins. IV. The Crystal Structure of a Zinc Complex of Pyridoxamine (Vitamin B6) Inorg. Chim. Acta. 1980;46:199–203. doi: 10.1016/S0020-1693(00)84191-2. [DOI] [Google Scholar]
  • 18.Ortega-Castro J., Adrover M., Frau J., Salvà A., Donoso J., Muñoz F. DFT Studies on Schiff Base Formation of Vitamin B6 Analogues. Reaction Between a Pyridoxamine-Analogue and Carbonyl Compounds. J. Phys. Chem. A. 2010;114:4634–4640. doi: 10.1021/jp909156m. [DOI] [PubMed] [Google Scholar]
  • 19.Adrover M., Vilanova B., Muñoz F., Donoso J. A Comparative Study of the Chemical Reactivity of Pyridoxamine, Ac-Phe-Lys and Ac-Cys with Various Glycating Carbonyl Compounds. Amino Acids. 2009;36:437–448. doi: 10.1007/s00726-008-0098-6. [DOI] [PubMed] [Google Scholar]
  • 20.Voziyan P.A., Metz T.O., Baynes J.W., Hudson B.G. A Post-Amadori Inhibitor Pyridoxamine Also Inhibits Chemical Modification of Proteins by Scavenging Carbonyl Intermediates of Carbohydrate and Lipid Degradation. J. Biol. Chem. 2002;277:3397–3403. doi: 10.1074/jbc.M109935200. [DOI] [PubMed] [Google Scholar]
  • 21.Chetykrin S., Zhang W., Hudson B.D., Serianni A.S., Voziyan P.V. Pyridoxamine Protects Protein from Functional Damage by 3-Deoxyglucosone: Mechanism of Action for Pyridoxamine. Biochemistry. 2008;47:997–1006. doi: 10.1021/bi701190s. [DOI] [PubMed] [Google Scholar]
  • 22.Halliwell B., Gutteridge J.M.C. Hydroxyl Radicals Assayed by Aromatic Hydroxylation and Deoxyribose Degradation. In: Greenwald R.A., editor. Handbook of Methods for Oxygen Radical Research. CRC Press; Boca Raton, FL, USA: 1986. pp. 177–180. [Google Scholar]
  • 23.Voziyan P.A., Hudson B.G. Pyridoxamine: The Many Virtues of a Maillard Reaction Inhibitor. Ann. N. Y. Acad. Sci. 2005;1043:807–816. doi: 10.1196/annals.1333.093. [DOI] [PubMed] [Google Scholar]
  • 24.Chetykrin S., Mathis M.E., Ham A.J.L., Hachey D.L., Hudson B.G., Voziyan P.V. Propagation of Protein Glycation Damage Involves Modification of Tryptophan Residues Via Reactive Oxygen Species: Inhibition by Pyridoxamine. Free Radic. Biol. Med. 2008;44:1276–1285. doi: 10.1016/j.freeradbiomed.2007.09.016. [DOI] [PubMed] [Google Scholar]
  • 25.Jain S.K., Lim G. Pyridoxine and Pyridoxamine Inhibits Superoxide Radicals and Prevents Lipid Peroxidation, Protein Glycosylation, and (Na++K+)-ATPase Activity Reduction in High Glucose-Treated Human Erythrocytes. Free Rad. Biol. Med. 2001;30:232–237. doi: 10.1016/S0891-5849(00)00462-7. [DOI] [PubMed] [Google Scholar]
  • 26.Cao G., Alessio H.M., Cutler R.G. Oxygen-Radical Absorbance Capacity Assay for Antioxidants. Free Radic. Biol. Med. 1993;14:303–311. doi: 10.1016/0891-5849(93)90027-R. [DOI] [PubMed] [Google Scholar]
  • 27.Blois M.S. Antioxidant Determinations by the Use of a Stable Free Radical. Nature. 1958;181:1199–1200. doi: 10.1038/1811199a0. [DOI] [Google Scholar]
  • 28.Matxain J., Ristila M., Strid A., Eriksson L.A. Theoretical Study of the Antioxidant Properties of Pyridoxine. J. Phys. Chem. A. 2006;110:13068–13072. doi: 10.1021/jp065115p. [DOI] [PubMed] [Google Scholar]
  • 29.Matxain J., Ristila M., Strid A., Eriksson L.A. Evidence of High •OH Radical Quenching Efficiency by Vitamin B6. J. Phys. Chem. B. 2009;113:9629–9632. doi: 10.1021/jp903023c. [DOI] [PubMed] [Google Scholar]
  • 30.Galano A., Alvarez-Idaboy J.R., Francisco-Márquez M., Medina M.E. A Quantum Chemical Study on the Free Radical Scavenging Activity of Tyrosol and Hydroxytyrosol. Theor. Chem. Acc. 2012;131:1–12. doi: 10.1007/s00214-012-1173-3. [DOI] [Google Scholar]
  • 31.León-Carmona J., Galano A. Is Caffeine a Good Scavenger of Oxygenated Free Radicals? J. Phys. Chem. B. 2011;115:4538–4546. doi: 10.1021/jp201383y. [DOI] [PubMed] [Google Scholar]
  • 32.Galano A., Alvarez-Idaboy J.R. Glutathione: Mechanism and Kinetics of Its Non-Enzymatic Defense Action Against Free Radicals. RSC Adv. 2011;1:1763–1771. doi: 10.1039/c1ra00474c. [DOI] [Google Scholar]
  • 33.Galano A., Francisco-Márquez M., Alvarez-Idaboy J.R. Canolol: A Promising Chemical Agent Against Oxidative Stress. J. Phys. Chem. B. 2011;115:8590–8596. doi: 10.1021/jp2022105. [DOI] [PubMed] [Google Scholar]
  • 34.Galano A. On the Direct Scavenging Activity of Melatonin Towards Hydroxyl and a Series of Peroxyl Radicals. Phys. Chem. Chem. Phys. 2011;13:7147–7157. doi: 10.1039/c0cp02801k. [DOI] [PubMed] [Google Scholar]
  • 35.Ortega-Castro J., Adrover M., Frau J., Donoso J., Muñoz F. Cu2+ Complexes of Some AGEs Inhibitors. Chem. Phys. Lett. 2009;475:277–284. doi: 10.1016/j.cplett.2009.05.074. [DOI] [Google Scholar]
  • 36.Ortega-Castro J., Frau J., Casasnovas R., Fernández D., Donoso J., Muñoz F. High- and Low-Spin Fe(III) Complexes of Various AGE Inhibitors. J. Phys. Chem. A. 2012;116:2961–2971. doi: 10.1021/jp210188w. [DOI] [PubMed] [Google Scholar]
  • 37.Casasnovas R., Ortega-Castro J., Donoso J., Frau J., Muñoz F. Theoretical Calculations of Stability Constants and pKa Values of Metal Complexes in Solution: Application to Pyridoxamine-Copper(II) Complexes and Their Biological Implications in AGE Inhibition. Phys. Chem. Chem. Phys. 2013;15:16303–16313. doi: 10.1039/c3cp50840d. [DOI] [PubMed] [Google Scholar]
  • 38.Adrover M., Vilanova B., Muñoz F., Donoso J. Pyridoxamine, A Scavenger Agent of Carbohydrates. Int. J. Chem. Kinet. 2007;39:154–167. doi: 10.1002/kin.20223. [DOI] [Google Scholar]
  • 39.Adrover M., Vilanova B., Muñoz F., Donoso J. Inhibition of Glycosylation Processes: The Reaction Between Pyridoxamine and Glucose. Chem. Biodivers. 2005;2:964–975. doi: 10.1002/cbdv.200590074. [DOI] [PubMed] [Google Scholar]
  • 40.Rose R.C., Bode A.M. Biology of Free Radical Scavengers. FASEB J. 1993;7:1135–1142. doi: 10.1096/fasebj.7.12.8375611. [DOI] [PubMed] [Google Scholar]
  • 41.Galano A., Tan D.X., Reiter R.J. Melatonin as a Naturall Ally Against Oxidative Stress: A Physicochemical Examination. J. Pineal Res. 2011;51:1–16. doi: 10.1111/j.1600-079X.2011.00916.x. [DOI] [PubMed] [Google Scholar]
  • 42.Galano A., Alvarez-Idaboy J.R. A Computational Methodology for Accurate Prediction of Rate Constants in Solution: Application to the Assessment of Primary Antioxidant Activity. J. Comput. Chem. 2013;34:2430–2445. doi: 10.1002/jcc.23409. [DOI] [PubMed] [Google Scholar]
  • 43.Zhao Y., Schultz N.E., Truhlar D.G. Design of Density Functionals by Combining the Method of Constraint Satisfaction with Parametrization for Thermochemistry, Thermochemical Kinetics, and Noncovalent Interactions. J. Chem. Theory Comput. 2006;2:364–382. doi: 10.1021/ct0502763. [DOI] [PubMed] [Google Scholar]
  • 44.Black G., Simmie J.M. Barrier Heights for H-Atom Abstraction by HO2• from n-Butanol—A Simple Yet Exacting Test for Model Chemistries? J. Comput. Chem. 2009;31:1236–1248. doi: 10.1002/jcc.21410. [DOI] [PubMed] [Google Scholar]
  • 45.Furuncuoǧlu T., Uǧur I., Deǧirmenci I., Aviyente V. Role of Chain Transfer Agents in Free Radical Polymerization Kinetics. Macromolecules. 2010;43:1823–1835. doi: 10.1021/ma902803p. [DOI] [Google Scholar]
  • 46.Zhao Y., Truhlar D.G. How Well Can New-Generation Density Functionals Describe the Energetics of Bond-Dissociation Reactions Producing Radicals? J. Phys. Chem. A. 2008;112:1095–1099. doi: 10.1021/jp7109127. [DOI] [PubMed] [Google Scholar]
  • 47.Marenich A.V., Cramer C.J., Truhlar D.G. Universal Solvation Model Based on Solute Electron Density and on a Continuum Model of the Solvent Defined by the Bulk Dielectric Constant and Atomic Surface Tensions. J. Phys. Chem. B. 2009;113:6378–6396. doi: 10.1021/jp810292n. [DOI] [PubMed] [Google Scholar]
  • 48.Vilanova B., Adrover M., Muñoz F., Donoso J. Photo-Induced Processes in Vitamin B6 Compounds. Chem. Biodivers. 2004;1:1073–1090. doi: 10.1002/cbdv.200490080. [DOI] [PubMed] [Google Scholar]
  • 49.Okuno Y. Theoretical Investigation of the Mechanism of the Baeyer-Villiger Reaction in Nonpolar Solvents. Chem. Eur. J. 1997;3:212–218. doi: 10.1002/chem.19970030208. [DOI] [PubMed] [Google Scholar]
  • 50.Benson S.W. The Foundations of Chemical Kinetics. Krieger; Malabar, FL, USA: 1982. [Google Scholar]
  • 51.Eckart C. The Penetration of a Potential Barrier by Electrons. Phys. Rev. 1930;35:1303–1309. doi: 10.1103/PhysRev.35.1303. [DOI] [Google Scholar]
  • 52.Brown R.L. A Method of Calculating Tunneling Corrections for Eckart Potential Barriers. J. Res. Natl. Bur. Stand. 1981;86:357–359. doi: 10.6028/jres.086.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Collins F.C., Kimball G.E. Diffusion-Controlled Reaction Rates. J. Colloid Sci. 1949;4:425–437. doi: 10.1016/0095-8522(49)90023-9. [DOI] [Google Scholar]
  • 54.Smoluchowski M.Z. Attempt for a Mathematical Theory of Kinetic Coagulation of Colloid Solutions. J. Phys. Chem. 1917;92:129–168. [Google Scholar]
  • 55.Stokes G.G. Mathematical and Physical Papers. Volume 3. Cambridge University Press; Cambridge, UK: 1903. p. 55. [Google Scholar]
  • 56.Einstein A. Motion of Suspended Particles in Stationary Liquids Required from the Molecular Kinetic Theory of Heat. Ann. Phys. 1905;17:549–560. doi: 10.1002/andp.19053220806. [DOI] [Google Scholar]
  • 57.Frisch M.J., Trucks G.W., Schlegel H.B., Scuseria G.E., Robb M.A., Cheeseman J.R., Scalmani G., Barone V., Mennucci B., Petersson G.A., et al. Gaussian09, Revision D.01. Gaussian, Inc.; Wallingford, CT, USA: 2013. [Google Scholar]
  • 58.Galano A., Martínez A. Capsaicin, a Tasty Free Radical Scavenger: Mechanism of Action and Kinetics. J. Phys. Chem. B. 2012;116:1200–1208. doi: 10.1021/jp211172f. [DOI] [PubMed] [Google Scholar]
  • 59.Amić A., Marković Z., Klein E., Dimitrić Marković J.M., Milenković D. Theoretical Study of the Thermodynamics of the Mechanisms Underlying Antiradical Activity of Cinnamic Acid Derivatives. Food Chem. 2018;246:481–489. doi: 10.1016/j.foodchem.2017.11.100. [DOI] [PubMed] [Google Scholar]
  • 60.Galano A., Francisco-Marquez M. Reactions of OOH Radical with β-Carotene, Lycopene, and Torulene: Hydrogen Atom Transfer and Adduct Formation Mechanisms. J. Phys. Chem. B. 2009;113:11338–11345. doi: 10.1021/jp904061q. [DOI] [PubMed] [Google Scholar]
  • 61.Galano A., Francisco-Marquez M. Peroxyl-Radical-Scavenging Activity of Garlic: 2-Propenesulfenic Acid versus Allicin. J. Phys. Chem. B. 2009;113:16077–16081. doi: 10.1021/jp907906h. [DOI] [PubMed] [Google Scholar]
  • 62.Burton G.W., Doba T., Gabe E., Hughes L., Lee F.L., Prasad L., Ingold K.U. Autoxidation of Biological Molecules. 4. Maximizing the Antioxidant Activity of Phenols. J. Am. Chem. Soc. 1985;107:7053–7065. doi: 10.1021/ja00310a049. [DOI] [Google Scholar]
  • 63.Galano A., León-Carmona J.R., Alvarez-Idaboy J.R. Influence of the Environment on the Protective Effects of Guaiacol Derivatives against Oxidative Stress: Mechanisms, Kinetics, and Relative Antioxidant Activity. J. Phys. Chem. B. 2012;116:7129–7137. doi: 10.1021/jp302810w. [DOI] [PubMed] [Google Scholar]
  • 64.Galano A., Alvarez-Idaboy J.R., Francisco-Márquez M. Physicochemical Insights on the Free Radical Scavenging Activity of Sesamol: Importance of the Acid/Base Equilibrium. J. Phys. Chem. B. 2011;115:13101–13109. doi: 10.1021/jp208315k. [DOI] [PubMed] [Google Scholar]
  • 65.Booth A.A., Khalifah R.G., Hudson B.G. Thiamine Pyrophosphate and Pyridoxamine Inhibit the Formation of Antigenic Advanced Glycation End-Products: Comparison with Aminoguanidine. Biochem. Biophys. Res. Commun. 1996;220:113–119. doi: 10.1006/bbrc.1996.0366. [DOI] [PubMed] [Google Scholar]
  • 66.Stocker P., Lesgards J.F., Vidal N., Chalier F., Prost M. ESR Study of a Biological Assay on Whole Blood: Antioxidant Efficiency of Various Vitamins. Biochim. Biophys. Acta Gen. Subj. 2003;1621:1–8. doi: 10.1016/S0304-4165(03)00008-4. [DOI] [PubMed] [Google Scholar]
  • 67.Merigliano C., Mascolo E., Burla R., Saggio I., Verni F. The Relationship Between Vitamin B6, Diabetes and Cancer. Front. Genet. 2018;9:1–5. doi: 10.3389/fgene.2018.00388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Voziyan P.A., Khalifah R.G., Thibaudeau C., Yildiz A., Jacob J., Serianni A.S., Hudson B.G. Modification of Proteins In Vitro by Physiological Levels of Glucose. J. Biol. Chem. 2003;278:46616–46624. doi: 10.1074/jbc.M307155200. [DOI] [PubMed] [Google Scholar]
  • 69.Nagaraj R.H., Sarkar P., Mally A., Biemel K.M., Lederer M.O., Padayatti P.S. Effect of Pyridoxamine on Chemical Modification of Proteins by Carbonyls in Diabetic Rats: Characterization of a Major Product from the Reaction of Pyridoxamine and Methylglyoxal. Arch. Biochem. Biophys. 2002;402:110–119. doi: 10.1016/S0003-9861(02)00067-X. [DOI] [PubMed] [Google Scholar]
  • 70.Amarnath V., Amarnath K., Amarnath K., Davies S., Roberts L.J. Pyridoxamine: An Extremely Potent Scavenger of 1,4-Dicarbonyls. Chem. Res. Toxicol. 2004;17:410–415. doi: 10.1021/tx0300535. [DOI] [PubMed] [Google Scholar]
  • 71.Ehrenshaft M., Jenns A.E., Chung K.R., Daub M.E. SOR1, a Gene Required for Photosensitizer and Singlet Oxygen Resistance in Cercospora Fungi, Is Highly Conserved in Divergent Organisms. Mol. Cell. 1998;1:603–609. doi: 10.1016/S1097-2765(00)80060-X. [DOI] [PubMed] [Google Scholar]
  • 72.Bilski P., Li M.Y., Ehrenshaft M., Daub M.E., Chignell C.F. Vitamin B6 (Pyridoxine) and Its Derivatives Are Efficient Singlet Oxygen Quenchers and Potential Fungal Antioxidants. Photochem. Photobiol. 2000;71:129–134. doi: 10.1562/0031-8655(2000)071&#x0003c;0129:SIPVBP&#x0003e;2.0.CO;2. [DOI] [PubMed] [Google Scholar]
  • 73.Denslow S.A., Walls A.A., Daub M.E. Regulation of Biosynthetic Genes and Antioxidant Properties of Vitamin B6 Vitamers During Plant Defense Responses. Physiol. Mol. Plant Pathol. 2005;66:244–255. doi: 10.1016/j.pmpp.2005.09.004. [DOI] [Google Scholar]
  • 74.Danon A., Miersch O., Felix G., Camp R.G.L., Apel K. Concurrent Activation of Cell Death-Regulating Signaling Pathways by Singlet Oxygen in Arabidopsis Thaliana. Plant J. 2005;41:68–80. doi: 10.1111/j.1365-313X.2004.02276.x. [DOI] [PubMed] [Google Scholar]
  • 75.Anand S.S. Protective Effect of Vitamin B6 in Chromium-Induced Oxidative Stress in Liver. J. Appl. Toxicol. 2005;25:440–443. doi: 10.1002/jat.1077. [DOI] [PubMed] [Google Scholar]
  • 76.Gliszczyńska-Świglo A. Antioxidant Activity of Water Soluble Vitamins in the TEAC (Trolox Equivalent Antioxidant Capacity) and the FRAP (Ferric Reducing Antioxidant Power) Assays. Food Chem. 2006;96:131–136. doi: 10.1016/j.foodchem.2005.02.018. [DOI] [Google Scholar]
  • 77.Matxain J.M., Ristilä M., Strid A., Eriksson L.A. Theoretical Study of the Reaction of Vitamin B6 with 1O2. Chem. Eur. J. 2007;13:4636–4642. doi: 10.1002/chem.200700002. [DOI] [PubMed] [Google Scholar]
  • 78.Škorňa P., Rimarčíc J., Poliak P., Lukeš V., Klein E. Thermodynamic Study of Vitamin B6 Antioxidant Potential. Comput. Theor. Chem. 2016;1077:32–38. doi: 10.1016/j.comptc.2015.10.010. [DOI] [Google Scholar]
  • 79.Abdullah K.M., Qais F.A., Ahmad I., Hasan H., Naseem I. Study of Pyridoxamine Against Glycation and Reactive Oxygen Species Production in Human Serum Albumin as Model Protein: An In Vitro & Ex Vivo Approach. Int. J. Biol. Macromol. 2018;120:1734–1743. doi: 10.1016/j.ijbiomac.2018.09.176. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials


Articles from Antioxidants are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES